Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > That's it for me.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(304)
•••
Comment by TommyNickelson Oct 25, 2024 4:15pm
282 Views
Post# 36282687

RE:RE:That's it for me.

RE:RE:That's it for me.Yup I sold. For the very reason of what just happened. Some guy just dumped 300K down to 26 cents. The close at 29 was the market makers trying to quiet things.

If BTD doesn't get filed soon, they will run out of cash.

I also didn't like Matthew saying they are still onboarding 5 new clinics to complete the study. These clinics aren't already ready to go??

I just worry that Theralase needed a pop in price to get warrant cash / PP investment to be able to complete the study so released an uber optimistic email. What if the "FDA will respond this week" turns into next week or the week after. What if key data is missing?

I couldn't risk it. Roger got banned once. And since he was wrong about pre-BTD in Q1. In Q2. In Q3. Why then should I believe Mondays email? Do zebras truly change their stripes?



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities